About

Founded in 2022, ImmunAdd, Inc., is a privately held biopharmaceutical company on a mission to improve health through advances in vaccine adjuvants, new formulation, and new drug design.

We will act with honesty, responsibility, sincerity, and empathy, with due consideration and respect for each other, our customers, collaborators, and vendors.